Dublin, Ireland, November 1, 2011. Seroba Kernel Life Sciences (Seroba Kernel) and Imperial Innovations Group (Innovations) have co-led a £5m funding round into Veryan Medical, which is developing innovative solutions for vascular disease using its unique Biomimics 3D™ stent technology.
Switzerland, September 20, 2011. Covagen announced today that Sir Gregory Winter is joining its Scientific Advisory Board. Sir Gregory Winter is a member of the Medical Research Council’s Laboratory of Molecular Biology (LMB) in Cambridge, and a Fellow of Trinity College Cambridge (UK).&
26th August 2011. Alimentary Health Limited (AH), the specialty biotechnology company, today announces that it has entered into a development partnership with Norgine, a leading European specialty pharmaceutical company with a strong portfolio of internal development projects, principally in tPrevious123456789101112Next